[Webinar] Evolving Markets Summit
(Trilliant Health, August 12, 1 pm EDT)
2020 has been a challenging year for hospitals. Record profits from United Healthcare. Walmart's expansion into primary care. Legal defeats on price transparency, site-neutral payments and 340B payments. And all of this in the midst of a global pandemic. The really bad news? It's only getting worse.
Join us as we discuss using data-driven strategies to understand the competitive dynamics that will shape your market over the next few years. With a more complete understanding of your health system's current market positioning, you can develop the strategies and tactics that will help your system not only survive but thrive.
[Article] Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
(The Lancet, July 20, 2020)
This study of the impact of treatment delays for cancer patients in England as a result of the COVID-19 lockdown likely has implications for U.S. cancer patients as well. As the study notes, cancer survival is similar across most economically developed countries, and the authors believe their estimates on the impact of delay in diagnosis and treatment are broadly applicable.
